Latham & Watkins LLP‘s global antitrust and competition team houses a merger control offering which is experienced in complex mandates, handling a range of high profile litigation and intricate investigations. Its collaboration with teams in Brussels and London is particularly notable, leveraging cross-border strength to support clients with international filings. Global chair Michael G. Egge, working out of Washington DC, leveraged international experience in his representation of Bunge Limited in its $34bn merger with Viterra, triggering filings in over 40 jurisdictions. Also in DC, Amanda Reeves handles a range of merger clearance, antitrust litigation, and conduct investigations, while Lindsey Champlin has sector expertise spanning energy, automotives, advertising, and live entertainment. Champlin acts as Vice Chair for the group alongside Belinda Lee, in the Bay Area. The DC-based team additionally includes Ian Conner, who brings experience at the FTC and has notable expertise regarding healthcare sector matters. New York-based Katherine Rocco is a go-to for clients in the sports sector, and offers particular expertise in antitrust litigation, and in the Bay Area, Kelly Fayne regularly supports technology and media companies from deal inception through to merger litigation.
Legal 500 redaktioneller Kommentar
Auszeichnungen
Mandantenzufriedenheit
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
- 'The Latham antitrust team is large and experienced, and can manage big projects with short deadlines.'
- 'Ian Conner is very good at what he does and is easy to work with.'
Kernmandanten
- Bunge Limited
- Endeavor
- American Red Cross
- American Airlines
- US Sugar
- Everwatch
- Apollo
- Chesapeake Energy
- Grail
- Abbott Laboratories
Highlight-Mandate
Advising Bunge Limited, a US grains merchant manufacturer, on the global merger control and FDI aspects for its merger with rival Viterra.
Advised Equitrans Midstream through the US deal clearance process for their US$35 billion merger with EQT Corporation.
Advised Cerevel Therapeutics, a biopharmaceutical company focused on developing new therapies to treat mood disorders, schizophrenia and Parkinson's disease, in its sale to AbbVie, a global biopharmaceutical company.
Anwält*innen
Hall of fame
Die Anwält*innen an der Spitze ihres Berufsstands, die aufgrund ihres langjährigen Engagements in marktführender Arbeit von Wettbewerbern und Mandanten gleichermaßen geschätzt und anerkannt werden.
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Partner*innen der nächsten Generation
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Praxisleitung
Michael G. Egge; Belinda Lee; Lindsey Champlin
Weitere Kernanwält*innen
Katherine Rocco; Kelly Fayne; Ian Conner; Farrell J. Malone; Makan Delrahim; Jason Cruise; Amanda Reeves